Press Release | NeoGenomics Laboratories

May 30, 2023

NeoGenomics to Showcase the Transformational Impact of RaDaR(R) Assay for Molecular Residual Disease and Recurrence Monitoring at ASCO

May 8, 2023

NeoGenomics Reports First Quarter 2023 Results

May 3, 2023

NeoGenomics to Participate at the BofA Securities 2023 Healthcare Conference

April 17, 2023

NeoGenomics to Announce First Quarter 2023 Financial Results

April 11, 2023

NeoGenomics to Participate at the 22nd Annual Needham Virtual Healthcare Conference

April 6, 2023

NeoGenomics to Share Nine Abstracts at the American Association of Cancer Research (AACR) Annual Meeting 2023

March 27, 2023

NeoGenomics to Host Investor Day on April 4, 2023

March 16, 2023

NeoGenomics Announces Commercial Availability of the RaDaR(R) Molecular Residual Disease Test

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients